Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Julian C, Schink"'
Autor:
Timothy L. Cannon, Ramya Thota, Nicole D. Fleming, Susan Halabi, Ricardo H. Alvarez, Jared Addison Cotta, Pam K. Mangat, Carmen Julia Calfa, Pamela A. Crilley, Sasha L. Warren, Andrew L. Rygiel, Theodore Pollock, Dan Veljovich, Elizabeth Garrett-Mayer, Julian C. Schink, Tareq Al Baghdadi, Julie Gottlieb Fisher, David Tait, Richard L. Schilsky
Publikováno v:
Targeted Oncology. 15:733-741
The Targeted Agent and Profiling Utilization Registry (TAPUR) Study, a phase II basket study, evaluates anti-tumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic alterations known as drug target
Autor:
Katherine E Poruk, Amber Moran, Vicki Doctor, Julia A Elvin, Saba Radhi, Arturo Loaiza-Bonilla, Hatem El Halabi, Julian C Schink, Maurie Markman
Publikováno v:
Journal of the American College of Surgeons. 235:S54-S54
Autor:
Katherine E Poruk, Amber Moran, Vicki Doctor, Julia Andrea Elvin, Saba Radhi, Arturo Loaiza-Bonilla, Julian C. Schink, Maurie Markman
Publikováno v:
Journal of Clinical Oncology. 40:4139-4139
4139 Background: Curative treatment of pancreatic adenocarcinoma (PDAC) remains a challenge, as most patients present with advanced disease that has spread to other organs. The main opportunity for cure for these individuals remains systemic therapy.
Autor:
Julian C. Schink, Ruchi Garg, Julia Andrea Elvin, Natalie Godbee, Amber Moran, Vicki Doctor, Bradford A. Tan, John H. Farley, Maurie Markman
Publikováno v:
Journal of Clinical Oncology. 40:5578-5578
5578 Background: Tumor genomic profiling is a critical component of precision oncology allowing the detection of genomic alterations (GA) that are potential therapeutic targets. We present an analysis of comprehensive genomic profiling (CGP) of a lar
Autor:
Ruchi Garg, Julian C. Schink, Barbara Buttin, Julia Andrea Elvin, Natalie Godbee, Amber Moran, Vicki Doctor, Bradford A. Tan, Judy Sequeria, John H. Farley, Maurie Markman
Publikováno v:
Journal of Clinical Oncology. 40:e17590-e17590
e17590 Background: Individualizing oncologic treatment by using precision oncology techniques that allow for detection of genomic alterations (GA) has become critical. We present an analysis of comprehensive genomic profiling (CGP) of a large series
Autor:
Navdha Mittal, Saurabh Malpani, Matthew Dyson, Masanori Ono, John S Coon, Julie J Kim, Julian C Schink, Serdar E Bulun, Mary Ellen Pavone
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110410 (2014)
Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring endometrial cancer. Fenretinide is a synthetic retinoid that has been evaluated in clinical trials as a cancer therapeutic and chemo-preventive agent. Fe
Externí odkaz:
https://doaj.org/article/f58977ee9afa495bb5d45984ddfced80
Autor:
Julie G, Fisher, David, Tait, Elizabeth, Garrett-Mayer, Susan, Halabi, Pam K, Mangat, Julian C, Schink, Ricardo H, Alvarez, Dan, Veljovich, Timothy L, Cannon, Pamela A, Crilley, Theodore, Pollock, Carmen J, Calfa, Tareq, Al Baghdadi, Ramya, Thota, Nicole, Fleming, Jared A, Cotta, Andrew L, Rygiel, Sasha L, Warren, Richard L, Schilsky
Publikováno v:
Targeted oncology. 15(6)
The Targeted Agent and Profiling Utilization Registry (TAPUR) Study, a phase II basket study, evaluates anti-tumor activity of commercially available targeted agents in patients with advanced cancers harboring genomic alterations known as drug target
Autor:
John R. Lurain, Julian C. Schink
Publikováno v:
Journal of Clinical Oncology. 38:4349-4350
Autor:
Pete Govorchin, Chevon Rariy, Eugene R Ahn, Katie Easthon, Bruce G. Gershenhorn, Bethany Garoutte, Julian C. Schink, Lynn Truesdale
Publikováno v:
Journal of Clinical Oncology. 39:e18528-e18528
e18528 Background: Americans who live in rural areas experience unique barriers to access healthcare such as limited transportation, shortages in oncology providers, limited access to advanced services which contribute to poor health outcomes. The cu
Autor:
Richard W. Lieberman, Kruti P. Maniar, Nilsa C. Ramirez, Meenakshi Singh, John R. Lurain, Angeles Alvarez Secord, Cara Mathews, Barbara M. Buttin, William T. Creasman, Kay J. Park, Jian-Jun Wei, Denise M. Scholtens, Heather A. Lankes, Floor J. Backes, Robert S. Mannel, David G. Mutch, Matthew A. Powell, Virginia L. Filiaci, Abigail Winder, Julian C. Schink, J. Julie Kim, David Peace, Dachao Liu, Michael L. Pearl
Publikováno v:
Cancer. 123:1144-1155
BACKGROUND Synuclein-γ (SNCG) is highly expressed in advanced solid tumors, including uterine serous carcinoma (USC). The objective of the current study was to determine whether SNCG protein was associated with survival and clinical covariates using